PMID- 31983918 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220412 IS - 1658-3639 (Print) IS - 1658-7774 (Electronic) IS - 1658-3639 (Linking) VI - 14 IP - 1 DP - 2020 Jan-Feb TI - Effect of bacillus bacterial extracts on the expression of major histocompatibility complex Class I and Class II receptors on MDA-MB 231 breast cancer cells. PG - 24-34 AB - OBJECTIVE: The expression of human leukocyte antigen (HLA)-ABC and HLA-DR is linked to the development of breast cancer. This study was aimed to determine the effect of bacillus bacterial extracts on the expression of the major histocompatibility complexes (MHC) Class I and Class II receptors on breast cancer cells. METHODS: The expression of HLA-ABC and HLA-DR was assessed by flow cytometry and confocal microscope on the human breast tumor cell lines MDA-MB-231, which used a readily accessible model system. It is postulated that the HLA-ABC and HLA-DR receptors might be regulated by bacillus bacterial extracts designated (RA10, RA4, RA7, and RA16). RESULTS: It was observed that the treatment of cell line MDA-MB-231 with the RA10 resulted in an upregulation of the cell surface expression of the HLA-A, B, C receptors. It was observed that RA10 has the capacity to reduce the expression of HLA-A, B, C, it also shows a detectable degree of cytotoxicity when used at high concentrations. The data show that the cell surface expression of HLA-ABC is higher than HLA-DR. No significant changes of HLA-DR expression were observed on MDA-MB-231 cell lines. CONCLUSIONS: Improved understanding of the connection between HLA-ABC, HLA-DR, and bacterial extracts such as RA10 may lead to the development of drug design and therapies related to breast cancer condition in which these receptors are involved. CI - Copyright: (c) International Journal of Health Sciences. FAU - Alabdulmonem, Waleed AU - Alabdulmonem W AD - Department of Pathology, College of Medicine, Qassim University, Buraidah, Kingdom of Saudi Arabia. LA - eng PT - Journal Article PL - Saudi Arabia TA - Int J Health Sci (Qassim) JT - International journal of health sciences JID - 101528042 PMC - PMC6968881 OTO - NOTNLM OT - Bacillus bacterial extracts OT - breast cancer cells OT - major histocompatibility complexes Class I receptor OT - major histocompatibility complexes Class II receptor EDAT- 2020/01/28 06:00 MHDA- 2020/01/28 06:01 PMCR- 2020/01/01 CRDT- 2020/01/28 06:00 PHST- 2020/01/28 06:00 [entrez] PHST- 2020/01/28 06:00 [pubmed] PHST- 2020/01/28 06:01 [medline] PHST- 2020/01/01 00:00 [pmc-release] AID - IJHS-14-24 [pii] PST - ppublish SO - Int J Health Sci (Qassim). 2020 Jan-Feb;14(1):24-34.